Trexquant Investment LP acquired a new position in shares of MiMedx Group, Inc (NASDAQ:MDXG) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 68,609 shares of the medical equipment provider’s stock, valued at approximately $815,000. Trexquant Investment LP owned approximately 0.06% of MiMedx Group as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Lourd Capital LLC grew its position in MiMedx Group by 0.4% during the 2nd quarter. Lourd Capital LLC now owns 31,120 shares of the medical equipment provider’s stock worth $466,000 after purchasing an additional 120 shares during the last quarter. Alps Advisors Inc. grew its position in MiMedx Group by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 56,871 shares of the medical equipment provider’s stock worth $851,000 after purchasing an additional 147 shares during the last quarter. Pinebridge Investments L.P. grew its position in MiMedx Group by 2.9% during the 2nd quarter. Pinebridge Investments L.P. now owns 13,438 shares of the medical equipment provider’s stock worth $201,000 after purchasing an additional 377 shares during the last quarter. Ameritas Investment Partners Inc. grew its position in MiMedx Group by 7.5% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 8,619 shares of the medical equipment provider’s stock worth $129,000 after purchasing an additional 600 shares during the last quarter. Finally, Louisiana State Employees Retirement System grew its position in MiMedx Group by 1.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 41,500 shares of the medical equipment provider’s stock worth $621,000 after purchasing an additional 700 shares during the last quarter. Hedge funds and other institutional investors own 70.64% of the company’s stock.

Several analysts have weighed in on MDXG shares. Needham & Company LLC started coverage on shares of MiMedx Group in a research report on Thursday, August 3rd. They set a “buy” rating on the stock. BidaskClub raised shares of MiMedx Group from a “hold” rating to a “buy” rating in a research report on Thursday, August 10th. Piper Jaffray Companies reissued a “buy” rating and set a $18.00 target price on shares of MiMedx Group in a research report on Sunday, August 20th. Finally, Zacks Investment Research downgraded shares of MiMedx Group from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. MiMedx Group presently has an average rating of “Hold” and an average target price of $15.40.

Shares of MiMedx Group, Inc (NASDAQ:MDXG) opened at $11.51 on Wednesday. The company has a market cap of $1,232.49, a price-to-earnings ratio of 52.86, a PEG ratio of 2.64 and a beta of 0.91. MiMedx Group, Inc has a twelve month low of $7.64 and a twelve month high of $17.47.

MiMedx Group (NASDAQ:MDXG) last released its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. The business had revenue of $84.60 million for the quarter, compared to the consensus estimate of $84.60 million. MiMedx Group had a net margin of 11.64% and a return on equity of 17.49%. The business’s revenue for the quarter was up 31.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.06 EPS. analysts predict that MiMedx Group, Inc will post 0.24 EPS for the current year.

MiMedx Group announced that its board has approved a stock repurchase plan on Monday, October 9th that allows the company to repurchase $10.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to purchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: This story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/11/29/trexquant-investment-lp-takes-815000-position-in-mimedx-group-inc-mdxg.html.

About MiMedx Group

MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.

Want to see what other hedge funds are holding MDXG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MiMedx Group, Inc (NASDAQ:MDXG).

Institutional Ownership by Quarter for MiMedx Group (NASDAQ:MDXG)

Receive News & Stock Ratings for MiMedx Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group Inc and related stocks with our FREE daily email newsletter.